Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Memphasys Ltd

MEM.AX ✗ NOT COMPLIANT ☆ Track — members

ASX · Healthcare · Advanced Medical Equipment & Technology ·

Australia Micro Cap Analyst: N/A

Last Close

$0.00

▲ +0.00%

Market Cap $13.34M · Vol 185.50K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$13.34M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

50.00

Momentum

Beta

0.49

vs Market

52W High

$0.01

31.08% below

52W Low

$0.00

122.73% above

Volume

185.50K

Avg 4.07M

P/B

1.83

Price-to-book

ROE

N/A

Return on equity

Free Float

61.30%

Public shares

Shariah Compliance8 STANDARDS

✗ Memphasys Ltd (MEM.AX) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MEM.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+20.00%

-14.29%

+9.09%

+0.00%

YTD

-14.29%

+80.00%

-37.46%

-89.12%

Financials & Valuation

TTM · Annual

Total Revenue	$2.44K
Net Income	$-3,315,708.00
Revenue Growth (YoY)	+235.30%
Gross Margin	-18,970.11%
Operating Margin	-96,278.86%
Net Profit Margin	-136,191.35%
ROE	N/A
ROA · ROIC	-44.37% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	3,626.31
P/B	1.83
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	3.09B

Technical Indicators

50-Day SMA	$0.00
200-Day SMA	$0.00
RSI (14)	50.00
Beta	0.49
52-Week High	$0.01
52-Week Low	$0.00

Volume Today	185.50K
Avg Daily Volume (30D)	4.07M
Relative Volume	0.05x
Volatility (10D)	111.69
Volatility (30D)	119.99
Free Float	61.30%

Analyst Consensus

N/A

Current Price $0.00

Mean Target N/A

52W Low$0.00 52W High$0.01

Current

Target

$0.00 $0.01

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIBBG001SNBJ48

ISINAU000000MEM5

CountryAustralia

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -0.75% DHR Danaher Corp -1.60% ISRG Intuitive Surgical Inc -0.85% BSX Boston Scientific Corp +1.81% EW Edwards Lifesciences Corp +0.13%

Company Profile

Memphasys Limited is an Australia-based reproductive biotechnology company. The Company is engaged in developing medical devices, diagnostics, and media with application to assisted reproductive technology (ART) in humans and animals. The Company's product pipeline includes Felix, RoXsta, and AI-Port. Its advanced product, the Felix System, is a patented automated device for quickly and gently separating sperm from a semen sample for use in ART procedures. The Felix device consists of two main components: a console, which supplies electrical power, and a sterile disposable cartridge for sperm isolation and selection. RoXsta is an in-vitro diagnostic device that assesses semen and other bodily fluids for oxidative stress load. RoXsta also has an application as part of a suite of products that can support the animal industry. AI-Port has been developed for the purpose of maintaining the viability of livestock semen for up to seven days at a temperature range of 22 - 25 degrees Celsius.